- List
- By Topic
- On Map
- Search Details

Holden Comprehensive Cancer Center AND Ascorbic Acid
Need help? See RSS Feeds
Choose a feed type:

Holden Comprehensive Cancer Center AND Ascorbic Acid (12 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT01515046 | Terminated Has Results |
Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
1 | All | 18 Years and older (Adult, Older Adult) | NCT01515046 | 201204737 P30CA086862 |
PACMAN-II | September 2012 | July 2015 | December 2016 | January 23, 2012 | June 8, 2017 | March 29, 2017 |
|
|
2 | NCT02344355 | Recruiting | A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
90 | All | 18 Years and older (Adult, Older Adult) | NCT02344355 | 201504786 | March 13, 2017 | April 2020 | December 2023 | January 22, 2015 | May 28, 2018 |
|
|||
3 | NCT02420314 | Recruiting | Pharmacological Ascorbate for Lung Cancer |
|
|
Interventional |
Phase 2 |
|
Other / NIH / Industry |
|
|
57 | All | 18 Years and older (Adult, Older Adult) | NCT02420314 | 201412760 3P30CA086862 |
April 2015 | December 2020 | December 2025 | April 17, 2015 | January 25, 2019 |
|
|||
4 | NCT01852890 | Active, not recruiting | Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
16 | All | 18 Years and older (Adult, Older Adult) | NCT01852890 | 201310772 | January 2014 | January 2019 | January 2020 | May 14, 2013 | September 18, 2018 |
|
|||
5 | NCT02905578 | Recruiting | A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) |
|
|
Interventional |
Phase 2 |
|
Other / NIH / Industry |
|
|
65 | All | 18 Years and older (Adult, Older Adult) | NCT02905578 | 201801759 3P30CA086862 5U01CA140206 |
November 5, 2018 | December 31, 2023 | December 31, 2025 | September 19, 2016 | November 9, 2018 |
|
|||
6 | NCT01049880 | Completed | A Research Trial of High Dose Vitamin C and Chemotherapy for Metastatic Pancreatic Cancer |
|
|
Interventional |
Phase 1 |
|
Other |
|
|
15 | All | 18 Years and older (Adult, Older Adult) | NCT01049880 | 200804753 | December 2009 | February 2013 | March 2013 | January 15, 2010 | April 21, 2017 |
|
|||
7 | NCT01752491 | Active, not recruiting | A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme |
|
|
Interventional |
Phase 1 |
|
Other / NIH |
|
|
13 | All | 18 Years and older (Adult, Older Adult) | NCT01752491 | 201211713 P30CA086862 U01CA140206 |
April 1, 2013 | November 30, 2015 | December 31, 2021 | December 19, 2012 | July 19, 2018 |
|
|||
8 | NCT03418038 | Recruiting | Ascorbic Acid and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Lymphoma |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
151 | All | 18 Years and older (Adult, Older Adult) | NCT03418038 | LS1781 NCI-2018-00057 P30CA015083 |
March 23, 2018 | March 15, 2024 | March 15, 2024 | February 1, 2018 | March 27, 2018 |
|
|||
9 | NCT03541486 | Not yet recruiting | A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients |
|
|
Interventional |
Phase 2 |
|
Other |
|
|
35 | All | 18 Years and older (Adult, Older Adult) | NCT03541486 | XACT-PANC-2 | XACT-PANC-2 | April 1, 2019 | December 31, 2028 | December 31, 2030 | May 30, 2018 | May 30, 2018 |
|
||
10 | NCT02905591 | Recruiting | A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC |
|
|
Interventional |
Phase 2 |
|
Other / NIH |
|
|
46 | All | 18 Years and older (Adult, Older Adult) | NCT02905591 | 201712770 3P30CA086862 5U01CA140206 1P01CA217797-01A1 |
XACT-LUNG | November 16, 2018 | July 2024 | July 2026 | September 19, 2016 | December 10, 2018 |
|
||
11 | NCT00079001 | Completed Has Results |
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases |
|
|
Interventional |
Phase 3 |
|
Other / NIH / Industry |
|
|
645 | Male | 18 Years and older (Adult, Older Adult) | NCT00079001 | CALGB-90202 U10CA031946 CAN-NCIC-PRC2 CDR0000353209 |
January 2004 | July 2012 | October 2014 | March 9, 2004 | December 20, 2016 | October 30, 2014 |
|
||
12 | NCT00288080 | Active, not recruiting Has Results |
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer |
|
|
Interventional |
Phase 3 |
|
Other / NIH |
|
|
612 | Male | 18 Years to 120 Years (Adult, Older Adult) | NCT00288080 | RTOG-0521 CDR0000462375 NCI-2009-00728 |
December 2005 | April 2014 | February 7, 2006 | June 8, 2018 | January 23, 2017 |
|
† Study has passed its completion date and status has not been verified in more than two years.